Author

Xiaohang Lu

Institutions: Shanghai Medical College of Fudan University, Dalian Medical University, Fudan University Shanghai Cancer Center, Second Affiliated Hospital of Dalian Medical University, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region

Observed institutions: Shanghai Medical College of Fudan University, Dalian Medical University, Fudan University Shanghai Cancer Center, Second Affiliated Hospital of Dalian Medical University, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Guangxi University of Chinese Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region

ORCID: 0009-0005-5807-6088

Observed ORCID: 0009-0005-5807-6088

OpenAlex ID: A5051596443

Integrated spatial and single cell transcriptomics identifies PRKDC as a dual prognostic biomarker and therapeutic target in hepatocellular carcinoma

2025 · Wenpeng Pang, Yunyong Wang, et al. · Scientific Reports · 9

ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification

2024 · Jiazhen Huang, Ying Tang, et al. · Cellular Signalling · 5

ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells

2023 · Jiazhen Huang, Wei Wei, et al. · Genes & Genomics · 5

BBOX1 mediates metabolic reprogramming driven by hypoxia and participates in the malignant progress of high-grade serous ovarian cancer

2024 · Jiazhen Huang, Ying Tang, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 4

Predicting Dropout Rates of MOOCs with Sliding Window Model

2017 · Xiaohang Lu, Shengqing Wang, et al. · Shuju fenxi yu zhishi faxian · 4

Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma

2025 · Xiaohang Lu, Yunyong Wang, et al. · Journal of Hepatocellular Carcinoma · 3

Hypoxia‐mediated high expression of TRIM15 promotes malignant progression of high‐grade serous ovarian cancer through activation of AKT signaling pathway by K63 ubiquitination

2025 · Wei Wei, Yang Zhang, et al. · International Journal of Cancer · 2

Hypoxia-induced PRPF19 modulates TPT1 alternative splicing to facilitate cisplatin resistance in high-grade serous ovarian cancer

2025 · Wei Wei, Yang Zhang, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2

Identification of Fanconi anemia pathway genes as novel prognostic biomarkers and therapeutic targets for breast cancer

2025 · Yunyong Wang, Xiaohang Lu, et al. · Translational Cancer Research · 1

Radical Hysterectomy, Complete Vaginectomy, and Vulvectomy With Dual-site Icg Mapping for Multifocal Genital Melanoma

2026 · Huijuan Yang, Boer Shan, et al. · International Journal of Gynecological Cancer

Mechanistic study of LINC00839-mediated suppression of anoikis in hepatocellular carcinoma via regulation of FOXM1

2026 · Xiaohang Lu, Minpeng Li, et al. · Translational Oncology

Development and Validation of a Predictive Model Combining [18F] FDG PET/CT and the Suidan Score for Primary Optimal Cytoreduction in Advanced High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study

2026 · Xiaohang Lu, Xiaomei Wang, et al. · Medical Science Monitor

Hypoxia- and Anoikis-Related lncRNA Signature Defines Molecular Subtypes and Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma [Corrigendum]

2025 · Xiaohang Lu, Yunyong Wang, et al. · Journal of Hepatocellular Carcinoma

An Integrated Multi-omics Analysis Predicts Neoadjuvant Chemotherapy Response in Advanced Ovarian Cancer

2025 · Wei Jiang, Yi Wang, et al. · International Journal of Gynecological Cancer

Combined impact of nutritional and inflammatory status and depressive symptoms on mortality following hysterectomy

2025 · Ying Yang, Yazhou Liu, et al. · BMC Women s Health

Works count: 15

Citation count: 35

H-index: 4

I10-index: